Common side effects (may affect up to 1 in 10 people): * Pain, redness, or swelling at the injection site * Nausea * Headache Uncommon side effects (may affect up to 1 in 100 people): * Diarrhea * Dizziness * Allergic reactions such as skin rash, itching, or hives Rare side effects (may affect up to 1 in 1,000 people): * Severe allergic reaction (anaphylaxis) with symptoms like difficulty breathing, swelling of the face or throat, and a drop in blood pressure
Canada Europe Germany France UK Italy Spain Netherlands Russia Rest of Europe Asia Pacific China Japan India Malaysia South Korea Indonesia Australia Vietnam Rest of Asia Pacific Middle East & Africa Saudi Arabia UAE Israel South Africa Rest of Middle East & Africa Latin America Mexico Brazil Argentina Rest of Latin America GLP-1 Market Report Scope Source: Polaris Market Research Analysis GLP-1 Market FAQ's The GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034
Transl Neurodegener (2017) 6:28
Understanding the Peptide-Curious Population The individuals exploring BPC-157 supplementation span diverse backgrounds, ages, and health goals, but common themes emerge in the peptide-curious population: Active Adults Experiencing Recovery Challenges: Many BPC-157 users are individuals in their 40s, 50s, and 60s who maintain active lifestyles but notice their bodies no longer recover as quickly from physical stress
Ishihara, K
,aspect=ignore)
